Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.74    0.13 (8.07%)
Bid:
1.61
Ask:
1.75
Spread: 0.14 (8.696%)
Market Cap: £34.91m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Valkor update

12 Jun 2026 07:00

RNS Number : 0182I
Quadrise PLC
12 June 2026
 

 

12 June 2026

Quadrise Plc ("Quadrise" or the "Company")

 

Valkor update

Quadrise Plc (AIM: QED), the technology company focused on the decarbonisation of shipping and heavy industry through deployment of low emission fuels and biofuels, provides an update on its project with Valkor Technologies LLC ("Valkor") in Utah, USA.

Progress with Valkor continues to be made towards pilot deployment and the commercial demonstration of the Company's upstream production model. The Quadrise equipment is ready for deployment and the Company has been informed that representative heavy sweet oil samples have been prepared in Valkor's new pilot plant ahead of MSAR® and bioMSAR™ formulation work.

Valkor's 500 barrel per day oil-sands pilot plant is now due to be commissioned in Q4 2026. The Company will not therefore deliver a 600 bpd Multifuel Manufacturing Unit ("MMU") to site by 30 June 2026 as had been previously indicated, this will now take place during Q3 2026.

Since the Company's announcement of 28 November 2025, no further licence fee payments have been received by the Company and US$0.95 million of the US$1.0 million licence fee payable to the Company by Valkor remains outstanding as Valkor await receipt of approved project funding. The Board now expects payment of the licence fee in full by 30 September 2026.

 

For further information please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Peter Borup, Chief Executive Officer

Jason Miles, Chief Technology Officer

 

 

Nominated Adviser

Cavendish Capital Markets Limited

 

 

+44 (0)20 7220 0500

Ben Jeynes

George Lawson

 

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Harry Davies-Ball (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

 

 

+44 (0)20 3005 5000

 

Public & Investor Relations

 

Tavistock Communications (Financial PR & IR)

Simon Hudson

Nick Elwes

Saskia Sizen

 

+44 (0) 20 7920 3150

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global shipping, power generation, industrial and refining industries. Learn more at: www.quadrise.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDFLFFQQLXBBK
Date   Source Headline
20th Jun 20149:30 amRNSAnnual Report and Notice of AGM
9th Jun 20144:30 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:30 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:30 pmRNSTotal Voting Rights
2nd Jun 20144:31 pmRNSBlocklisting Interim Review
2nd Jun 20144:30 pmRNSHolding(s) in Company
28th May 20144:30 pmRNSHolding(s) in Company
28th May 20144:29 pmRNSAdditional Listing
27th May 20144:30 pmRNSDirector/PDMR Shareholding
23rd May 20147:00 amRNSFinal Results for the year ended 31 March 2014
16th May 20147:00 amRNSDisposal of share in iQ JV to Wellcome Trust
8th May 20149:01 amRNSNotice of Results
7th May 20144:30 pmRNSDirector/PDMR Shareholding
2nd May 20144:01 pmRNSTotal Voting Rights
2nd May 20144:00 pmRNSDirector/PDMR Shareholding
1st May 20147:00 amRNSQuintain acquires Aldermary House, EC4
14th Apr 20147:00 amRNSRe Joint Venture at Wembley Park
11th Apr 20144:38 pmRNSHolding(s) in Company
9th Apr 20144:31 pmRNSReplacement Director/PDMR Shareholding
2nd Apr 20144:31 pmRNSTotal Voting Rights
2nd Apr 20144:30 pmRNSDirector/PDMR Shareholding
26th Mar 20144:30 pmRNSHolding(s) in Company
26th Mar 20143:00 pmRNSDirector Declaration
11th Mar 20149:03 amRNSDirector/PDMR Shareholding
4th Mar 20144:31 pmRNSTotal Voting Rights
4th Mar 20144:30 pmRNSDirector/PDMR Shareholding
14th Feb 20145:17 pmRNSHolding(s) in Company
12th Feb 20144:30 pmRNSHolding(s) in Company
12th Feb 20147:00 amRNSDisposal of interest in Mitre Passage
12th Feb 20147:00 amRNSInterim Management Statement
7th Feb 20147:00 amRNSQuintain acquires Kingsbourne House
4th Feb 20144:31 pmRNSTotal Voting Rights
4th Feb 20144:28 pmRNSDirector/PDMR Shareholding
30th Jan 20144:30 pmRNSDirector/PDMR Shareholding
7th Jan 20144:32 pmRNSBlocklisting Interim Review
7th Jan 20144:31 pmRNSBlocklisting Interim Review
7th Jan 20144:30 pmRNSDirector/PDMR Shareholding
7th Jan 20144:30 pmRNSDirector/PDMR Shareholding
7th Jan 20144:30 pmRNSTotal Voting Rights
27th Dec 20139:43 amRNSHolding(s) in Company
10th Dec 20139:30 amRNSDirector/PDMR Shareholding
5th Dec 20131:05 pmRNSHolding(s) in Company
3rd Dec 20139:30 amRNSHolding(s) in Company
3rd Dec 20139:06 amRNSTotal Voting Rights
3rd Dec 20139:05 amRNSDirector/PDMR Shareholding
25th Nov 20137:00 amRNSResults for the six months ended 30 September 2013
21st Nov 20131:15 pmRNSGeneral Meeting voting results
8th Nov 20134:00 pmRNSNotice of Interim Results
7th Nov 20134:30 pmRNSDirector/PDMR Shareholding
7th Nov 201311:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.